Pfizer to earmark 3 million COVID vaccines for Israel, officials say
Prime Minister Benjamin Netanyahu spoke on the matter with Pfizer CEO Albert Bourla. It remains unclear when the vaccine will become available globally. Israel also has a deal with US biotech firm Moderna, which is expected to announce its vaccine's clinical trial results later this month.









